Dr. Levin is the Chairman and CEO of Ovid Therapeutics Inc., a company dedicated to providing innovative medicines to children and adults with neurological disorders.[2][3] Ovid’s initial product development programs are focused on orphan and rare diseases of the brain, including Angelman syndrome and Fragile X syndrome.
Prior to joining Ovid, Dr. Levin served as President and CEO of Teva Pharmaceutical Industries Ltd.
